Skip to content

Effect of Gonadotropin-releasing hormone analogue( GnRh-a ) for in vitro fertillization cycles (IVF)

Effect of gonadotropin-releasing hormone analogue (GnRh-a ) for triggering and luteal phase support in antagonist –in vitro fertillization cycles (IVF) in normal responders and comprission with standard protocol

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160722029027N7
Enrollment
72
Registered
2019-07-08
Start date
2018-04-04
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Noninflammatory disorders of female genitalia tract. Complication associated with artificial fertilization, unspecified

Interventions

Intervention 1: Intervention group: Subcutaneous injection of Triptorelin(0/2 mg each of them 0/1 mg variopeptyl company ) for trigger of follicle only single dose( on triggering day). Intervention 2

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women aged 20-40 years normal respondering in IVF cycles Body mass index between 20-30 Fresh embryo transfer cycles Serum FSH of third menstrual day below 10 and absence of low ovarian response according bologna criteria

Exclusion criteria

Exclusion criteria: Failed fertilization Sever endometriosis Decreased ovarian reserve. Unwillingness to continue Absence of good quality embryo Ovarian stimulation hyper stimulation (more than 18 mature follicles during ovarian stimulation )

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal Ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: serum ßHcG test.;OOcyte number. Timepoint: After ovarian puncture. Method of measurement: Evaluation with reproductive biologist after ovarian puncture.

Secondary

MeasureTime frame
Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion rate. Timepoint: Loss of pregnancy before 20 weeks. Method of measurement: Ultrasonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHashemi Teibeh

Shahid Beheshti University of Medical Sciences

hashemit89@yahoo.com+98 31 5546 0180

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026